IPO Trending
VILINBIOSME / NSEListed
Vilin Bio Med

Incorporated in 2005, Vilin Bio Med Limited is engaged in the domestic manufacturing of pharmaceutical products, supplying in bulk to pharmaceutical manufacturers, marketers, and traders who distribute them to end customers. The company’s product range includes Oral Liquids (Syrups, Suspensions, Dry Powders – both βeta and Non-βeta-Lactam), Tablets and Capsules (βeta and Non-βeta-Lactam), External Preparations, and Dry Powders. Vilin Bio Med operates its R&D center and manufacturing facility in Roorkee, Uttarakhand, ensuring quality and innovation in production. The company reported revenue of ₹1,121.91 lakhs in FY2022 and ₹1,171.88 lakhs in FY2021.

₹30 - ₹302.82x sub
Listed Price₹30.00
Listing Gain+0.00%

Subscription Status

2.82xTotal Demand
Updated 20 Oct 2026, 01:30 AM
Nib1.48x
Fully Subscribed (Safe)Offered: 17,92,000 sh
Retail4.02x
Popular / Warm DemandOffered: 20,00,000 sh
CategoryOfferedAppliedTimes
Nib17,92,00026,44,0001.48x
Retail20,00,00080,40,0004.02x

Segment Subscription Demand

Segment / CategoryDemand (Shares)Offered (Shares)Times Sub.
Retail24.1264.02x
Bidding status cross-verified with live IPO subscription numbers ↗BSE & NSE Bidding Portal Feed

About Vilin Bio Med IPO Subscription Demand

Live subscription status and bidding analysis for Vilin Bio Med (VILINBIO) IPO. The issue is subscribed 2.82x overall across Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII/HNI), and Retail Individual Investors (RII). Check real-time grey market demand on our GMP Tracker or review full issue details, lot size, and price band on the IPO Details Page.

Frequently Asked Questions